Company Axa Pharm Medchim Srl with Fiscal Code 30411040
recorded a turnover of 2024 of
4.586,
with a net profit of
-1.068
and having an average number of employees of
- .
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Axa Pharm Medchim Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
52.773
25.358
15.608
18.541
18.047
34.607
8.905
11.769
9.021
4.586
Total Income - EUR
52.773
25.359
15.608
18.541
18.048
34.607
8.905
11.772
9.056
4.634
Total Expenses - EUR
40.656
16.175
11.079
13.200
4.888
26.146
13.433
10.386
22.099
5.703
Gross Profit/Loss - EUR
12.118
9.184
4.529
5.341
13.160
8.461
-4.529
1.386
-13.043
-1.068
Net Profit/Loss - EUR
10.535
8.539
4.061
4.785
12.619
7.423
-4.796
1.040
-13.043
-1.068
Employees
1
1
0
0
0
0
0
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -48.9%, from 9.021 euro in the year 2023, to 4.586 euro in 2024.
Check the financial reports for the company - Axa Pharm Medchim Srl
Financial Rating - AXA PHARM MEDCHIM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Axa Pharm Medchim Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Axa Pharm Medchim Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Axa Pharm Medchim Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Axa Pharm Medchim Srl - CUI 30411040
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
51.313
61.633
66.081
30.652
42.183
53.096
28.702
30.381
20.752
18.541
Inventories
31.278
30.016
28.443
27.921
27.734
30.963
9.789
11.353
7.479
6.836
Receivables
1.384
599
3.005
1.867
2.563
3.512
2.584
14.928
12.920
11.278
Cash
18.651
31.018
34.634
865
11.886
18.621
16.328
4.101
354
427
Shareholders Funds
9.470
17.912
21.670
26.057
38.171
44.870
18.702
19.800
7.958
6.845
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
41.843
43.720
44.411
4.596
4.012
8.226
9.999
10.581
12.794
11.696
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
18.541 euro in 2024 which includes Inventories of
6.836 euro, Receivables of
11.278 euro and cash availability of
427 euro.
The company's Equity was valued at
6.845 euro, while total Liabilities amounted to
11.696 euro.
Equity decreased by -1.068 euro, from 7.958 euro in 2023, to 6.845 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Axa Pharm Medchim Srl